<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00076219</url>
  </required_header>
  <id_info>
    <org_study_id>530</org_study_id>
    <nct_id>NCT00076219</nct_id>
  </id_info>
  <brief_title>Acute Renal Failure Trial Network (ATN) Study</brief_title>
  <acronym>ATN</acronym>
  <official_title>CSP #530 - Intensive vs. Conventional Renal Support in Acute Renal Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, prospective, randomized, parallel-group trial of an intensive
      strategy vs conventional strategy of renal replacement therapy for the treatment of acute
      renal failure secondary to acute tubular necrosis in critically ill patients. The primary
      hypothesis is that the intensive strategy will reduce 60-day all cause mortality by 10%
      compared to the conventional strategy - i.e.,a reduction from 55% in the conventional arm to
      45% in the intensive arm. Secondary outcomes are 60-day in-hospital all-cause mortality,
      1-year all cause mortality, and recovery of renal function by day 28. The study will recruit
      1164 patients over a period of 3 years, 8 months and each patient will be actively followed
      for 60 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Hypothesis: An intensive management strategy for renal support in critically ill
      patients with acute renal failure decreases mortality as compared to less intensive
      (conventionally recommended) management strategies for renal replacement therapy.

      Secondary Hypotheses: An intensive management strategy for renal support in critically ill
      patients with acute renal failure will shorten the duration of ARF, decrease the incidence
      and duration of non-renal complications and is cost-effective as compared to less intensive
      (conventionally recommended) management strategies for renal replacement therapy.

      Primary Outcomes: 60-day all-cause mortality.

      Secondary Outcomes: All-cause hospital mortality; 1-year all cause mortality; recovery of
      renal function; duration of renal support (dialysis-free days); ICU and hospital length of
      stay (ICU-and hospital-free days); non-renal organ system failures (organ-failure-free days);
      and discharge to &quot;home&quot; not on dialysis.

      Study Abstract: The optimal management of renal replacement therapy (RRT) in acute renal
      failure (ARF) is uncertain. The VA/NIH Acute Renal Failure Trial Network (ATN Study) is
      designed to test the hypothesis that a strategy of intensive renal support will decrease
      mortality in critically ill patients with ARF as compared to less intensive (conventionally
      recommended) management. In this multicenter, prospective trial, patients with ARF due to
      acute tubular necrosis will be randomized equally to intensive or conventional management
      strategies for RRT.

      In both arms, RRT will be initiated using the same criteria. Hemodynamically stable patients
      (SOFA cardiovascular score: 0-2) will receive intermittent hemodialysis (IHD) while
      hemodynamically unstable patients (SOFA cardiovascular score: 3-4) will be treated with
      continuous venovenous hemodiafiltration (CVVHDF) or sustained low-efficiency hemodialysis
      (SLED). Patients will convert between modalities of therapy as hemodynamic status changes
      over time. The intensity of therapy in IHD and SLED will vary between groups based on
      treatment frequency; with treatments provided 6-times per week in the intensive management
      strategy arm and 3-times per week in the conventional management strategy arm. In CVVHDF,
      intensity of therapy will vary based on effluent flow rate with a prescribed flow rate of 35
      mL/kg/hour in the intensive management strategy arm and 20 mL/kg/hour in the conventional
      management strategy arm.

      Protocol therapy will be continued until renal function recovers or until day 28. The primary
      study end-point will be 60-day all-cause mortality. Other end-points will include hospital
      and 1-year mortality, recovery of renal function, duration of renal support, ICU and hospital
      length of stay, hospital discharge off of dialysis and development/recovery of non-renal
      organ failure. An economic analysis will be performed to assess the costs and relative cost
      effectiveness of the two strategies.

      The planned total enrollment of 1164 patients at 27 institutions over 44 months was selected
      to provide a power of 0.90 to detect a reduction in mortality from 55% to 45% with alpha=0.05
      assuming a dropout/loss-to-follow-up rate of 10%.

      Study enrollment began in November 2003 and closed after 44 months on July 2, 2007. Total
      enrollment was 1124 subjects. Fewer than 3% of subjects withdrew from protocol therapy.
      Follow-up for the primary study endpoint (60-day all-cause mortality) concluded on August 31,
      2007; one-year follow-up will conclude in July 2008.

      A type of dialysis solution used in the study was under IND with No. 67,631 and granted by
      Center for Drug Evaluation and Research in FDA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>60-day All-cause Mortality</measure>
    <time_frame>60 days</time_frame>
    <description>60-day all-cause mortality</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1124</enrollment>
  <condition>Acute Renal Failure</condition>
  <arm_group>
    <arm_group_label>Intensive renal replacement therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 6 times per week, and continuous venovenous hemodiafiltration was provided at 35 mL/kg/hour.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Less-intensive renal replacement therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the less-intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 3 times per week, and continuous venovenous hemodiafiltration was provided at 20 mL/kg/hour.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>renal replacement therapy</intervention_name>
    <description>renal replacement therapy</description>
    <arm_group_label>Intensive renal replacement therapy</arm_group_label>
    <arm_group_label>Less-intensive renal replacement therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute renal failure clinically consistent with a diagnosis of acute tubular necrosis

          -  Plan for renal replacement therapy by clinical team

          -  Receiving care in a critical care unit

          -  One non-renal organ failure or sepsis

          -  Age 18 or older

          -  Patient or surrogate provides informed consent

        Exclusion Criteria:

          -  Baseline serum creatinine &gt; 2 mg/dL (177 mol/L) in males, &gt; 1.5 mg/dL (133 mol/L) in
             females

          -  Acute renal failure clinically believed to be due to an etiology other than acute
             tubular necrosis

          -  More than 72 hours since meeting both of the following conditions:

               1. Fulfillment of the definition of ARF; and

               2. BUN &gt; 100 mg/dL (36 mmol/L)

          -  More than 1 hemodialysis treatment or more than 24 hours since starting continuous
             renal replacement therapy

          -  Prior kidney transplant

          -  Pregnancy

          -  Prisoner

          -  Weight &gt; 128.5 kg

          -  Non-candidacy for renal replacement therapy

          -  Moribund state

          -  Patient not expected to survive 28 days because of underlying terminal chronic medical
             condition

          -  Comfort-measures-only status

          -  Participation in a concurrent interventional study

          -  Patient/surrogate refusal

          -  Physician refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul M. Palevsky</last_name>
    <role>Study Chair</role>
    <affiliation>VA Pittsburgh Health Care System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock</name>
      <address>
        <city>No. Little Rock</city>
        <state>Arkansas</state>
        <zip>72114-1706</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System, West LA</name>
      <address>
        <city>West Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Eastern Colorado Health Care System, Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Connecticut Health Care System (West Haven)</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Augusta</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Richard Roudebush VA Medical Center, Indianapolis</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202-2884</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Maryland Health Care System, Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Jamaica Plain Campus</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Ann Arbor Healthcare System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, St Louis</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Western New York Healthcare System at Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University School of Medicine</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157-1053</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Portland</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Pittsburgh Health Care System</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212-2637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA North Texas Health Care System, Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michael E. DeBakey VA Medical Center (152)</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hunter Holmes McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System, Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008 Jul 3;359(1):7-20. doi: 10.1056/NEJMoa0802639. Epub 2008 May 20. Erratum in: N Engl J Med. 2009 Dec 10;361(24):2391.</citation>
    <PMID>18492867</PMID>
  </results_reference>
  <results_reference>
    <citation>Palevsky PM, O'Connor TZ, Chertow GM, Crowley ST, Zhang JH, Kellum JA; US Department of Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network. Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. Crit Care. 2009;13(4):310. doi: 10.1186/cc7901. Epub 2009 Aug 11.</citation>
    <PMID>19678919</PMID>
  </results_reference>
  <results_reference>
    <citation>Palevsky PM, O'Connor T, Zhang JH, Star RA, Smith MW. Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials. 2005;2(5):423-35.</citation>
    <PMID>16317811</PMID>
  </results_reference>
  <results_reference>
    <citation>Johansen KL, Smith MW, Unruh ML, Siroka AM, O'Connor TZ, Palevsky PM; VA/NIH Acute Renal Failure Trial Network. Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol. 2010 Aug;5(8):1366-72. doi: 10.2215/CJN.02570310. Epub 2010 May 27.</citation>
    <PMID>20507953</PMID>
  </results_reference>
  <results_reference>
    <citation>Joyce VR, Smith MW, Johansen KL, Unruh ML, Siroka AM, O'Connor TZ, Palevsky PM; Veteran Affairs/National Institutes of Health Acute Renal Failure Trial Network. Health-related quality of life as a predictor of mortality among survivors of AKI. Clin J Am Soc Nephrol. 2012 Jul;7(7):1063-70. doi: 10.2215/CJN.00450112. Epub 2012 May 17.</citation>
    <PMID>22595826</PMID>
  </results_reference>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2004</study_first_submitted>
  <study_first_submitted_qc>January 16, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2004</study_first_posted>
  <results_first_submitted>June 12, 2013</results_first_submitted>
  <results_first_submitted_qc>June 12, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 16, 2013</results_first_posted>
  <last_update_submitted>August 16, 2013</last_update_submitted>
  <last_update_submitted_qc>August 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Renal Failure</keyword>
  <keyword>Renal Replacement Therapy</keyword>
  <keyword>multi-site randomization trial</keyword>
  <keyword>Hemodialysis</keyword>
  <keyword>Hemofiltration</keyword>
  <keyword>Critical Illness</keyword>
  <keyword>Hemodiafiltration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intensive Renal Replacement Therapy</title>
          <description>In the intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 6 times per week, and continuous venovenous hemodiafiltration was provided at 35 mL/kg/hour.</description>
        </group>
        <group group_id="P2">
          <title>Less-intensive Renal Replacement Therapy</title>
          <description>In the less-intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 3 times per week, and continuous venovenous hemodiafiltration was provided at 20 mL/kg/hour.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="563"/>
                <participants group_id="P2" count="561"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="545"/>
                <participants group_id="P2" count="550"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intensive Renal Replacement Therapy</title>
          <description>In the intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 6 times per week, and continuous venovenous hemodiafiltration was provided at 35 mL/kg/hour.</description>
        </group>
        <group group_id="B2">
          <title>Less-intensive Renal Replacement Therapy</title>
          <description>In the less-intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 3 times per week, and continuous venovenous hemodiafiltration was provided at 20 mL/kg/hour.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="563"/>
            <count group_id="B2" value="561"/>
            <count group_id="B3" value="1124"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="341"/>
                    <measurement group_id="B2" value="335"/>
                    <measurement group_id="B3" value="676"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="222"/>
                    <measurement group_id="B2" value="226"/>
                    <measurement group_id="B3" value="448"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.6" spread="15.3"/>
                    <measurement group_id="B2" value="59.7" spread="15.2"/>
                    <measurement group_id="B3" value="59.7" spread="15.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>One subject has missing gender.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="154"/>
                    <measurement group_id="B2" value="176"/>
                    <measurement group_id="B3" value="330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="409"/>
                    <measurement group_id="B2" value="384"/>
                    <measurement group_id="B3" value="793"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>60-day All-cause Mortality</title>
        <description>60-day all-cause mortality</description>
        <time_frame>60 days</time_frame>
        <population>Number of all-cause mortality by day 60</population>
        <group_list>
          <group group_id="O1">
            <title>Intensive Renal Replacement Therapy</title>
            <description>In the intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 6 times per week, and continuous venovenous hemodiafiltration was provided at 35 mL/kg/hour.</description>
          </group>
          <group group_id="O2">
            <title>Less-intensive Renal Replacement Therapy</title>
            <description>In the less-intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 3 times per week, and continuous venovenous hemodiafiltration was provided at 20 mL/kg/hour.</description>
          </group>
        </group_list>
        <measure>
          <title>60-day All-cause Mortality</title>
          <description>60-day all-cause mortality</description>
          <population>Number of all-cause mortality by day 60</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="563"/>
                <count group_id="O2" value="561"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="302"/>
                    <measurement group_id="O2" value="289"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.47</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.09</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.12</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.86</ci_lower_limit>
            <ci_upper_limit>1.40</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intensive Renal Replacement Therapy</title>
          <description>In the intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 6 times per week, and continuous venovenous hemodiafiltration was provided at 35 mL/kg/hour.</description>
        </group>
        <group group_id="E2">
          <title>Less-intensive Renal Replacement Therapy</title>
          <description>In the less-intensive management strategy, intermittent hemodialysis and sustained low-efficiency dialysis were provided 3 times per week, and continuous venovenous hemodiafiltration was provided at 20 mL/kg/hour.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDra 10.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="287" subjects_at_risk="563"/>
                <counts group_id="E2" subjects_affected="280" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Histiocytosis haematophagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="563"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Electromechanical dissociation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Mitral valve disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pericardial rub</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Rhythm idioventricular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Ventricular failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Sickle cell anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Sickle cell anaemia with crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Oesophageal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Catheter site haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="40" subjects_affected="40" subjects_at_risk="563"/>
                <counts group_id="E2" events="48" subjects_affected="46" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Alcoholic liver disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="563"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hepatitis alcoholic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Graft versus host disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Heart transplant rejection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Lung transplant rejection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Catheter related infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Catheter site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Endocarditis staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Enterococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Fungaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Fungal sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Lung infection pseudomonal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pneumococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pneumonia adenoviral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="34" subjects_affected="32" subjects_at_risk="563"/>
                <counts group_id="E2" events="35" subjects_affected="33" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="563"/>
                <counts group_id="E2" events="33" subjects_affected="31" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Chemical poisoning</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Complications of bone marrow transplant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Haemodialysis-induced symptom</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Medication error</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Non-accidental overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Transplant failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Haematocrit decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Lactic acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Lip and/or oral cavity cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Neuroendocrine tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Ovarian cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Anoxic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hypoxic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Bronchial obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Chronic obstructive airways disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Respiratory tract haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Tracheal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abscess drainage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Aortic valve replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Cardiac operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Colectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Coronary artery surgery</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Thoracotomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Ventricular septal defect repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Air embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Haemodynamic instability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hypoperfusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="82" subjects_affected="58" subjects_at_risk="563"/>
                <counts group_id="E2" events="78" subjects_affected="50" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="563"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="563"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="561"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Paul M. Palevsky MD</name_or_title>
      <organization>VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA</organization>
      <phone>410-360-3932</phone>
      <email>paul.palevsky@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

